Resultados da busca - Llombart-Cussac, Antonio
- Mostrando 1 - 20 resultados de 37
- Ir para a próxima página
-
1
Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects por Gion, María, Pérez-García, José Manuel, Llombart-Cussac, Antonio, Sampayo-Cordero, Miguel, Cortés, Javier, Malfettone, Andrea
Publicado em 2021Texto -
2
Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019 por Di Cosimo, Serena, Malfettone, Andrea, Pérez-García, José M., Llombart-Cussac, Antonio, Miceli, Rosalba, Curigliano, Giuseppe, Cortés, Javier
Publicado em 2020Texto -
3
Lymphopenia in hospitalized patients and its relationship with severity of illness and mortality por Andreu-Ballester, Juan Carlos, Pons-Castillo, Aurelio, González-Sánchez, Antonio, Llombart-Cussac, Antonio, Cano, María José, Cuéllar, Carmen
Publicado em 2021Texto -
4
Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy por Honrubia-Peris, Beatriz, Garde-Noguera, Javier, García-Sánchez, Jose, Piera-Molons, Nuria, Llombart-Cussac, Antonio, Fernández-Murga, María Leonor
Publicado em 2021Texto -
5
Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, wit... por Garde Noguera, Javier, Jantus-Lewintre, Eloisa, Gil-Raga, Mireia, Evgenyeva, Elena, Maciá Escalante, Sonia, Llombart-Cussac, Antonio, Camps Herrero, Carlos
Publicado em 2017Texto -
6
-
7
The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II) por Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Malfettone, Andrea, Pérez-García, José Manuel, Llombart-Cussac, Antonio, Cortés, Javier, Pardo, Almudena, Pérez-López, Jordi
Publicado em 2020Texto -
8
The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Thera... por Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Malfettone, Andrea, Pérez-García, José Manuel, Llombart-Cussac, Antonio, Cortés, Javier, Pardo, Almudena, Pérez-López, Jordi
Publicado em 2021Texto -
9
Nobody dares stopping clinical research, not even COVID-19 por Malfettone, Andrea, Di Cosimo, Serena, Pérez-García, José Manuel, García, Alicia, Sampayo-Cordero, Miguel, Mina, Leonardo, Herrero, Carolina, Llombart-Cussac, Antonio, Cortés, Javier
Publicado em 2021Texto -
10
Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy por Di Leo, Angelo, O’Shaughnessy, Joyce, Sledge, George W., Martin, Miguel, Lin, Yong, Frenzel, Martin, Hardebeck, Molly C., Smith, Ian C., Llombart-Cussac, Antonio, Goetz, Matthew P., Johnston, Stephen
Publicado em 2018Texto -
11
Progress Against Solid Tumors in Danger: The Metastatic Breast Cancer Example por Cortés, Javier, Calvo, Emiliano, González-Martín, Antonio, Dawood, Shaheenah, Llombart-Cussac, Antonio, De Mattos-Arruda, Leticia, Gómez, Patricia, Silva, Orlando, Perez, Edith A., Rugo, Hope S., Lluch, Ana, Hortobagyi, Gabriel N.
Publicado em 2012Texto -
12
Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population por Garde-Noguera, Javier, Fernández-Murga, M. Leonor, Giner-Bosch, Vicent, Dominguez-Márquez, Victoria, Sánchez, José García, Soler-Cataluña, Juan José, López Chuliá, Franscica, Honrubia, Beatriz, Piera, Nuria, Llombart-Cussac, Antonio
Publicado em 2020Texto -
13
Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type... por Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Pardo-Mateos, Almudena, Malfettone, Andrea, Pérez-García, José, Llombart-Cussac, Antonio, Cortés, Javier, Moltó-Abad, Marc, Muñoz-Delgado, Cecilia, Pérez-Quintana, Marta, Pérez-López, Jordi
Publicado em 2019Texto -
14
Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors por Andreu-Ballester, Juan Carlos, Galindo-Regal, Lorena, Hidalgo-Coloma, Julia, Cuéllar, Carmen, García-Ballesteros, Carlos, Hurtado, Carolina, Uribe, Natalia, del Carmen Martín, María, Jiménez, Ana Isabel, López-Chuliá, Francisca, Llombart-Cussac, Antonio
Publicado em 2020Texto -
15
Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design por Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Pérez-García, José, Páez, David, Guerrero-Zotano, Ángel L., Garde-Noguera, Javier, Aguirre, Elena, Holgado, Esther, López-Miranda, Elena, Huang, Xin, Malfettone, Andrea, Llombart-Cussac, Antonio, Cortés, Javier
Publicado em 2020Texto -
16
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-neg... por Inoue, Kenichi, Masuda, Norikazu, Iwata, Hiroji, Takahashi, Masato, Ito, Yoshinori, Miyoshi, Yasuo, Nakayama, Takahiro, Mukai, Hirofumi, van der Walt, Jan-Stefan, Mori, Joji, Sakaguchi, Sachi, Kawaguchi, Tsutomu, Tanizawa, Yoshinori, Llombart-Cussac, Antonio, Sledge, George W., Toi, Masakazu
Publicado em 2021Texto -
17
Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial por López-Miranda, Elena, Pérez-García, José Manuel, Di Cosimo, Serena, Brain, Etienne, Ravnik, Maja, Escrivá-de-Romaní, Santiago, Vidal, Maria, Gligorov, Joseph, Borštnar, Simona, Calabuig, Laura, Sampayo-Cordero, Miguel, Malfettone, Andrea, Llombart-Cussac, Antonio, Suter, Thomas M., Cortés, Javier
Publicado em 2020Texto -
18
A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole por Garcia-Casado, Zaida, Guerrero-Zotano, Angel, Llombart-Cussac, Antonio, Calatrava, Ana, Fernandez-Serra, Antonio, Ruiz-Simon, Amparo, Gavila, Joaquin, Climent, Miguel A, Almenar, Sergio, Cervera-Deval, Jose, Campos, Josefina, Albaladejo, Carlos Vazquez, Llombart-Bosch, Antonio, Guillem, Vicente, Lopez-Guerrero, Jose A
Publicado em 2010Texto -
19
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2: A Randomiz... por Sledge, George W., Toi, Masakazu, Neven, Patrick, Sohn, Joohyuk, Inoue, Kenichi, Pivot, Xavier, Burdaeva, Olga, Okera, Meena, Masuda, Norikazu, Kaufman, Peter A., Koh, Han, Grischke, Eva-Maria, Conte, PierFranco, Lu, Yi, Barriga, Susana, Hurt, Karla, Frenzel, Martin, Johnston, Stephen, Llombart-Cussac, Antonio
Publicado em 2019Texto -
20
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial por Pascual, Tomás, Oliveira, Mafalda, Villagrasa, Patricia, Ortega, Vanesa, Paré, Laia, Bermejo, Begoña, Morales, Serafín, Amillano, Kepa, López, Rafael, Galván, Patricia, Canes, Jordi, Salvador, Fernando, Nuciforo, Paolo, Rubio, Isabel T., Llombart-Cussac, Antonio, Di Cosimo, Serena, Baselga, José, Harbeck, Nadia, Prat, Aleix, Cortés, Javier
Publicado em 2021Texto